Falcone A - Search Results

1

Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients.

Scartozzi M, Bearzi I, Mandolesi A, Giampieri R, Faloppi L, Galizia E, Loupakis F, Zaniboni A, Zorzi F, Biscotti T, Labianca R, Falcone A, Cascinu S. Scartozzi M, et al. Among authors: falcone a. Br J Cancer. 2011 May 24;104(11):1786-90. doi: 10.1038/bjc.2011.161. Epub 2011 May 10. Br J Cancer. 2011. PMID: 21559018 Free PMC article.

2

Suramin in patients with metastatic colorectal cancer pretreated with fluoropyrimidine-based chemotherapy. A phase II study.

Falcone A, Pfanner E, Cianci C, Danesi R, Brunetti I, Del Tacca M, Conte PF. Falcone A, et al. Cancer. 1995 Jan 15;75(2):440-3. doi: 10.1002/1097-0142(19950115)75:2<440::aid-cncr2820750205>3.0.co;2-3. Cancer. 1995. PMID: 7812913 Clinical Trial.

3

Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma.

Rosso R, Mazzei T, Sobrero A, Mini E, Cartei G, Conte P, Labianca R, Cartei F, Falcone A, Pancera G, et al. Rosso R, et al. Among authors: falcone a. Eur J Cancer. 1994;30A(3):338-43. doi: 10.1016/0959-8049(94)90253-4. Eur J Cancer. 1994. PMID: 8204356 Clinical Trial.

4

Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy.

Falcone A, Pfanner E, Brunetti I, Allegrini G, Lencioni M, Galli C, Masi G, Danesi R, Antonuzzo A, Del Tacca M, Conte PF. Falcone A, et al. Tumori. 1998 Nov-Dec;84(6):666-8. doi: 10.1177/030089169808400610. Tumori. 1998. PMID: 10080673

5

Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study.

Falcone A, Allegrini G, Lencioni M, Pfanner E, Brunetti I, Cianci C, Galli C, Masi G, Antonuzzo A, Conte P. Falcone A, et al. Cancer Chemother Pharmacol. 1999;44(2):159-63. doi: 10.1007/s002800050961. Cancer Chemother Pharmacol. 1999. PMID: 10412951 Clinical Trial.

6

Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinoma.

Falcone A, Antonuzzo A, Danesi R, Allegrini G, Monica L, Pfanner E, Masi G, Ricci S, Del Tacca M, Conte P. Falcone A, et al. Cancer. 1999 Aug 1;86(3):470-6. doi: 10.1002/(sici)1097-0142(19990801)86:3<470::aid-cncr15>3.0.co;2-7. Cancer. 1999. PMID: 10430255 Clinical Trial.

7

A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study.

Gridelli C, Gallo C, Di Maio M, Barletta E, Illiano A, Maione P, Salvagni S, Piantedosi FV, Palazzolo G, Caffo O, Ceribelli A, Falcone A, Mazzanti P, Brancaccio L, Capuano MA, Isa L, Barbera S, Perrone F. Gridelli C, et al. Among authors: falcone a. Br J Cancer. 2004 Dec 13;91(12):1996-2004. doi: 10.1038/sj.bjc.6602241. Br J Cancer. 2004. PMID: 15558071 Free PMC article. Clinical Trial.

8

Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.

Sobrero A, Frassineti G, Falcone A, Dogliotti L, Rosso R, Di Costanzo F, Bruzzi P; INTACC. Sobrero A, et al. Among authors: falcone a. Br J Cancer. 2005 Jan 17;92(1):24-9. doi: 10.1038/sj.bjc.6602276. Br J Cancer. 2005. PMID: 15611795 Free PMC article. Clinical Trial.

9

First-line 5-fluorouracil/folinic acid, oxaliplatin and irinotecan (FOLFOXIRI) does not impair the feasibility and the activity of second line treatments in metastatic colorectal cancer.

Masi G, Marcucci L, Loupakis F, Cerri E, Barbara C, Bursi S, Allegrini G, Brunetti IM, Murr R, Ricci S, Cupini S, Andreuccetti M, Falcone A. Masi G, et al. Among authors: falcone a. Ann Oncol. 2006 Aug;17(8):1249-54. doi: 10.1093/annonc/mdl119. Epub 2006 Jun 9. Ann Oncol. 2006. PMID: 16766580 Free article. Clinical Trial.

10

Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy.

Ruzzo A, Graziano F, Loupakis F, Santini D, Catalano V, Bisonni R, Ficarelli R, Fontana A, Andreoni F, Falcone A, Canestrari E, Tonini G, Mari D, Lippe P, Pizzagalli F, Schiavon G, Alessandroni P, Giustini L, Maltese P, Testa E, Menichetti ET, Magnani M. Ruzzo A, et al. Among authors: falcone a. Pharmacogenomics J. 2008 Aug;8(4):278-88. doi: 10.1038/sj.tpj.6500463. Epub 2007 Jun 5. Pharmacogenomics J. 2008. PMID: 17549067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

690 results

Search Page

Filters